Aricept Evess

Aricept Evess

donepezil

Manufacturer:

Eisai
Concise Prescribing Info
Contents
Donepezil HCl
Indications/Uses
Symptomatic treatment of mild, moderate & severe Alzheimer's disease (AD).
Dosage/Direction for Use
Adult & elderly Mild to moderate Alzheimer's disease Initially 5 mg/day in the evening (prior to retiring). Dose can be increased to 10 mg/day after at least 1 mth of clinical assessment of treatment at 5 mg/day. Max: 10 mg/day. Severe Alzheimer's disease 10 mg/day, only after daily dose of 5 mg for 4-6 wk. If not tolerated, reduce to 5 mg.
Administration
May be taken with or without food: Place on the  tongue & allow to disintegrate before swallowing w/ or w/o water.
Contraindications
Hypersensitivity to piperidine derivatives.
Special Precautions
Underlying cardiac condition abnormalities, history of ulcer disease or those receiving concurrent NSAIDs, history of asthma or obstructive pulmonary disease. May impair ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Diarrhea, muscle cramps, fatigue, nausea, vomiting, insomnia, headache, anorexia, hallucination, agitation, aggressive behavior, depression, abnormalities, somnolence, syncope, dizziness, abdominal disturbance, rash, pruritus, urinary incontinence, pain, decreased wt, ecchymosis, infection.
Drug Interactions
Anesth, ketoconazole, quinidine, dexamethasone, phenobarb, rifampicin, phenytoin, carbamazepine, drugs w/ anticholinergic activity, succinylcholine, other neuromuscular blockers or cholinergic agonists eg, bethanechol.
MIMS Class
Neurodegenerative Disease Drugs
ATC Classification
N06DA02 - donepezil ; Belongs to the class of anticholinesterases. Used in the management of dementia.
Presentation/Packing
Form
Aricept Evess orodispersible tab 10 mg
Packing/Price
2 × 14's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in